Skip to main content
Top
Published in: Surgery Today 10/2012

01-10-2012 | Original Article

Natural course of venous malformation after conservative treatment

Authors: Woo-Sung Yun, Dong-Ik Kim, Young-Nam Rho, Young-Soo Do, Kwang-Bo Park, Keon-Ha Kim, Hong-Suk Park, Young-Wook Kim, Ui-Jun Park, Nari Kim, Shin-Young Woo

Published in: Surgery Today | Issue 10/2012

Login to get access

Abstract

Purpose

To investigate the clinical course of patients with venous malformation (VM) treated conservatively.

Methods

We reviewed retrospectively the database of our Congenital Vascular Malformation clinic and interviewed 207 patients with VM, who had been managed only conservatively. The questionnaires asked about changes in size (no change, increase in proportion to growth, increase greater than in proportion to growth, decrease) and changes in symptoms (markedly worse, moderately worse, no change, moderately improved, markedly much improved). Progression of VMs was defined as an increase greater than in proportion to growth or worsening symptoms.

Results

Fifty patients (24 %) reported an increase in size greater than in proportion to growth and 25 patients (12 %) reported symptoms worsening from their initial symptoms. Overall, sixty-six (32 %) of the patients reported evidence of progression of their VM. A binary logistic regression model identified VM combined with capillary malformation (CM) or lymphatic malformation (LM) as an independent predictor of VM progression (OR 2.67, 95 % CI 1.29–5.53).

Conclusions

Based on responses to the questionnaire, the size and symptoms of VM progressed in 32 % of patients over the course of their life. VMs combined with CM or LM were the only independent predictor of progression of a VM after conservative management.
Literature
1.
go back to reference Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg. 2005;32:99–116. ix.CrossRefPubMed Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg. 2005;32:99–116. ix.CrossRefPubMed
2.
go back to reference Lee BB, Laredo J, Lee TS, Huh S, Neville R. Terminology and classification of congenital vascular malformations. Phlebology. 2007;22:249–52.CrossRefPubMed Lee BB, Laredo J, Lee TS, Huh S, Neville R. Terminology and classification of congenital vascular malformations. Phlebology. 2007;22:249–52.CrossRefPubMed
3.
4.
go back to reference Lee BB, Laredo J, Kim YW, Neville R. Congenital vascular malformations: general treatment principles. Phlebology. 2007;22:258–63.CrossRefPubMed Lee BB, Laredo J, Kim YW, Neville R. Congenital vascular malformations: general treatment principles. Phlebology. 2007;22:258–63.CrossRefPubMed
5.
go back to reference Belov S. Classification of congenital vascular defects. Int Angiol. 1990;9:141–6.PubMed Belov S. Classification of congenital vascular defects. Int Angiol. 1990;9:141–6.PubMed
6.
go back to reference Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg. 2003;37:533–8.CrossRefPubMed Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg. 2003;37:533–8.CrossRefPubMed
7.
go back to reference Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412–22.CrossRefPubMed Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412–22.CrossRefPubMed
8.
go back to reference Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 1996;87:1181–90.CrossRefPubMed Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 1996;87:1181–90.CrossRefPubMed
9.
go back to reference Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA. 2002;99:11205–10.CrossRefPubMedPubMedCentral Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA. 2002;99:11205–10.CrossRefPubMedPubMedCentral
10.
go back to reference Redondo P, Aguado L, Marquina M, Paramo JA, Sierra A, Sanchez-Ibarrola A, et al. Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies. Br J Dermatol. 2010;162:350–6.CrossRefPubMed Redondo P, Aguado L, Marquina M, Paramo JA, Sierra A, Sanchez-Ibarrola A, et al. Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies. Br J Dermatol. 2010;162:350–6.CrossRefPubMed
11.
go back to reference Duyka LJ, Fan CY, Coviello-Malle JM, Buckmiller L, Suen JY. Progesterone receptors identified in vascular malformations of the head and neck. Otolaryngol Head Neck Surg. 2009;141:491–5.CrossRefPubMed Duyka LJ, Fan CY, Coviello-Malle JM, Buckmiller L, Suen JY. Progesterone receptors identified in vascular malformations of the head and neck. Otolaryngol Head Neck Surg. 2009;141:491–5.CrossRefPubMed
12.
go back to reference Kim YW. Proper selection of patients for percutaneous embolo-sclerotherapy in patients with congenital vascular malformations (CVMs). Eur J Vasc Endovasc Surg. 2010;39(Suppl 1):S49–54.CrossRefPubMed Kim YW. Proper selection of patients for percutaneous embolo-sclerotherapy in patients with congenital vascular malformations (CVMs). Eur J Vasc Endovasc Surg. 2010;39(Suppl 1):S49–54.CrossRefPubMed
13.
go back to reference Goyal M, Causer PA, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology. 2002;223:639–44.CrossRefPubMed Goyal M, Causer PA, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology. 2002;223:639–44.CrossRefPubMed
14.
go back to reference Jin Y, Lin X, Li W, Hu X, Ma G, Wang W. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations. J Vasc Surg. 2008;47:1292–9.CrossRefPubMed Jin Y, Lin X, Li W, Hu X, Ma G, Wang W. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations. J Vasc Surg. 2008;47:1292–9.CrossRefPubMed
15.
go back to reference Wang YA, Zheng JW, Zhu HG, Ye WM, He Y, Zhang ZY. Sclerotherapy of voluminous venous malformation in head and neck with absolute ethanol under digital subtraction angiography guidance. Phlebology. 2010;25:138–44.CrossRefPubMed Wang YA, Zheng JW, Zhu HG, Ye WM, He Y, Zhang ZY. Sclerotherapy of voluminous venous malformation in head and neck with absolute ethanol under digital subtraction angiography guidance. Phlebology. 2010;25:138–44.CrossRefPubMed
16.
go back to reference Yun WS, Kim YW, Lee KB, Kim DI, Park KB, Kim KH, et al. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg. 2009;50:581–9. 9 e1.CrossRefPubMed Yun WS, Kim YW, Lee KB, Kim DI, Park KB, Kim KH, et al. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg. 2009;50:581–9. 9 e1.CrossRefPubMed
17.
go back to reference Hein KD, Mulliken JB, Kozakewich HP, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002;110:1625–35.CrossRefPubMed Hein KD, Mulliken JB, Kozakewich HP, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002;110:1625–35.CrossRefPubMed
18.
go back to reference Malan E, Puglionisi A. Congenital angiodysplasias of the extremities. I. Generalities and classification; venous dysplasias. J Cardiovasc Surg (Torino). 1964;5:87–130. Malan E, Puglionisi A. Congenital angiodysplasias of the extremities. I. Generalities and classification; venous dysplasias. J Cardiovasc Surg (Torino). 1964;5:87–130.
Metadata
Title
Natural course of venous malformation after conservative treatment
Authors
Woo-Sung Yun
Dong-Ik Kim
Young-Nam Rho
Young-Soo Do
Kwang-Bo Park
Keon-Ha Kim
Hong-Suk Park
Young-Wook Kim
Ui-Jun Park
Nari Kim
Shin-Young Woo
Publication date
01-10-2012
Publisher
Springer Japan
Published in
Surgery Today / Issue 10/2012
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-012-0185-x

Other articles of this Issue 10/2012

Surgery Today 10/2012 Go to the issue